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Abstract
Neural tube defects (NTD) are among the 
most common and disabling birth defects. 
The aetiology of NTD is unknown and their 
genetics are complex. The majority of 
NTD cases are sporadic, isolated, non- 
syndromic, and generally considered to be 
multifactorial in origin. Recently, PAX3 
(formerly HuP2, the human homologue of 
mouse Pax-3), on chromosome 2q35-37, 
was suggested as a candidate gene for NTD 
because mutations of Pax-3 cause the 
mouse mutant Splotch (£ƒ>), an animal 
model for human NTD. Mutations in PAX3 
were also identified in patients with Waar- 
denburg syndrome type 1 (WS1). At least 
eight patients with both WS1 and NTD 
have been described suggesting pleiotropy 
or a contiguous gene syndrome.
Seventeen US families and 14 Dutch 
families with more than one affected per­
son with NTD were collected and 194 
people (50 affected) from both data sets 
were genotyped using the PAX3 poly­
morphic marker. The data were analysed 
using affecteds only linkage analysis. The 
lod scores were —7*30 (US), —3*74 
(Dutch), and —11*04 (combined) at 0 = 0*0, 
under the assumption of the autosomal 
dominant model. For the recessive model, 
the lod scores were —3*30 (US), —1*46 
(Dutch), and —4-76 (combined) at 0 = 0-0.
Linkage between PAX3 and familial 
NTD was excluded to 9 • 9 cM on either side 
of the gene for the dominant model and to 
3*63 cM on either side of the gene for the 
recessive model in the families studied. 
No evidence of heterogeneity was detected 
using the HOMOG program. Our data 
indicate that PAX3 is not a major gene for 
NTD.
( J  M ed  Genet 1995;32:200-204)
Neural tube defects (NTD) are among the 
most common birth defects and have been 
associated with certain syndromes and chro­
mosome abnormalities (including trisomies 13, 
18, and 2 1 ) 1 and an X  linked condition . 2" 5 The 
majority of N T D  cases are sporadic, isolated, 
non-syndromic, and generally considered to be 
multifactorial in origin with a heritability 
of about 70 to 80%.6 However, a number 
of familial cases have been documented im­
plicating genetic susceptibility factors in fa­
milial N T D . 7' 12
T he mouse m utant Splotch (Sp) has long
been recognised as a model for human N T D . 
Splotch homozygotes develop spina bifida, 
meningocele, and exencephaly . 13 Most mutants 
die in utero. Splotch heterozygotes have pig­
mentation defects resulting in white feet, tail 
tip, and belly patch. These pigmentation de­
fects as well as deficiencies in neural crest 
derived tissues and cells (NCC), that is, spinal 
ganglia and Schwann cells, are caused by the 
failure of N C C to populate these regions suf­
ficiently during development . 1314 Mutations in 
the Pax-3 gene result in the Sp phenotype . 15 
The paired box containing genes, the Pax 
genes, encode for sequence specific DNA bind­
ing transcription factors that play a role in 
embryonic development. To date, nine pax 
genes, Paxl-9> have been isolated . 1416 Pax-3 is 
expressed in the neural tube, in the N C C 3 in 
the dermomyotome of the developing somites, 
in limb buds, and in the developing brain . 1 4 1 7  
The Pax-3 gene, located on mouse chro­
mosome 1, is homologous to the human PAX3 
or formerly HuP2 gene at 2q35-37 . 14 Mutations 
in PAX3 have been described in patients with 
Waardenburg syndrome type 1  (WS1 ), a syn­
drome consisting of pigmentary disturbances 
resulting from abnormalities related to N C C  
emigration, a pathogenesis similar to that of Sp  
mice . 18' 20 Reports of at least eight patients with 
both W Sl and N TD  raise the possibility of 
pleiotropy or a contiguous gene syndrome . 2 1 “ 23 
To test this hypothesis, we conducted linkage 
analysis on 31 N TD  families using the PAX3 
polymorphic marker.
Patients and methods
PATIENTS, FAMILY, AND CLINICAL EVALUATION
Families from the United States were as­
certained by referrals from spina bifida clinics, 
and by responses of patients to notices in 
patient newsletters. Our specific request was 
for families with more than one case of spina 
bifida cystica (SB) or other N TD . Syndromic or 
chromosome abnormality cases were excluded. 
Diagnoses were based on detailed clinical in­
formation from interviews by us, from direct 
review of the medical records (31 records), or 
from medical record review by physicians and  
nurses in the referring SB clinics. Information 
obtained for index and other cases included: 
family pedigree, number of affected cases in 
each family, sex, ethnic background, and b irth  
dates of the cases, their mothers, and their 
fathers.
For the Dutch families, criteria for selection 
of cases and information obtained were similar. 
These families were selected in collaboration
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with the D utch  patient organisation BOSK 
and from the records of University Hospital 
Nijmegen.
D N A  from 1 0 2  subjects in 17 US families 
and from 92 subjects in 14 D utch families were 
collected. Twenty-nine living affected patients 
from US families had SB, and two additional 
people had spina bifida occulta (SBO). Sev­
enteen living affected subjects from Dutch 
families had SB, two had SBO, and one had 
encephalocele (EC). DNA was not available 
from 13 patients with SB (US families) and 15 
patients with SB, seven with anencephaly (AC), 
and two with SB and AC (Dutch families). 
Pedigrees of all informative families are shown 
in the figure. There were five families with sib 
pairs only (two of those were Hispanic).
Among the 17 US families, 14 were white 
with multiple ethnicities including British, 
D utch, French, German, Irish, Italian, N or­
wegian, Russian, Scottish, and Swedish. Three 
families were Hispanic. All the D utch families 
were white.
DNA M ETHODS AND PO LY M O RPH ISM  ANALYSIS
Blood samples were collected after informed 
consent was obtained and their transformed 
cell lines we :e established. D N A  was prepared 
from each transformed cell line by standard 
m ethods . 24 T he short tandem repeat poly­
morphism (STRP) located on the 5' side of 
exon 1  of the PAX3 gene was used . 25 We de­
signed a new set of primers flanking the same 
repeat in order to reduce the size of the PCR 
products. This made it easier to separate the 
different alleles on acrylamide gel. Forward
primer: 5'-AGTTGCTGAGGGCGGAGAAG- 
3' and reverse primer: S'-GAAATCACAAGA- 
GGATAGAGGCT-3'. Product sizes were 192 
to 218 bp. D N A  was amplified by PC R  using 
published conditions25 in a 25 \x\ reaction
Table 1 Lod scores under dominant model, penetrance =  0'45
0
0-0 0*01 0-05 0*1 0*2 0*3 0*4
us -7 -3 — 5*14 -2*94 ■— 1 *68 -0-59 -0 -2 0 -0*06
Dutch -3 -74 -2 -1 0 — 0*58 — 0-04 0-24 0*20 0*10
Sum -11-04 -7*24 -3 -5 2 —1*72 -0*35 0*00 0-04
Table 2 Lod scores under recessive model] penetrance = 0-45
0
0-0 0*01 0-05 0*1 0*2 0-3 0*4
US -3*30 -2*57 -1*16 -0*45 0-02 0-08 0*04
Dutch —1*46 -1*09 -0*31 0*09 0*28 0-21 0*09
Sum -4*76 -3 -6 6 - 1  -47 -0 -3 6 0*30 0-29 0*13
Table 3 Lod scows under dominant model, penetrance ~  0-27
0
0*0 0*01 0*05 0*1 0*2 0*3 0*4
US -6*21 -4*57 -2 -6 8 —1*57 -0*56 -0*19 -0*05
Dutch -3*01 -1*88 — 0*54 — 0*02 0*24 0*20 0*09
Sum -9*22 -6 -4 5 — 3-22 -1*59 -0*32 0*01 0*04
mixture containing 2 0  ng of genomic 
DNA, 10 mmol/1 Tris-Cl, 1*5 mmol/1 MgCl2, 
50 mmol/1 KC1, 200 jamol/1 dATP, 200 jimol/1 
dGTP, 200 jamo 1/1 dTTP, 2-5 (.imol/1 dCTP, 
25 nmol/132P-ot-dCTP, 15 pmol of each primer, 
and 0-25 units of Taq DNA polymerase. PCR 
products were separated on 6 % acrylamide 
(19:1 bis) gels, and autoradiographically 
visualised by a 1 to 16 hour exposure to Kodak 
X-AR film.
LINKAGE ANALYSIS OF PAX3 AND NTD
The incidence of SB is 4*3/10 000 live births 
in the US, and 1 / 1 0 0 0  live births for N TD s 
in the Netherlands . 2627 The difference in in­
cidence results from the fact that affected sub­
jects in the US data only had SB and SBO, 
whereas affected subjects in the Dutch data 
had varieties of N T D : SB, AC, and EC. The 
penetrance for genetic cases of SB was 0-45 
based on the published data , 11 and for genetic 
cases of N T D  was 0*27. The phenocopy fre­
quency was based on the estimation that 50% 
of the cases are non-genetic. The analysis was 
also performed under the assumption of pheno­
copy rate of zero. Disease allele frequencies 
were calculated from disease incidence and 
penetrances.
Linkage analysis was performed using the 
LINKAGE computer package (version 5-1) . 28 
Because of the unclear mode of inheritance of 
SB and N T D , we performed analyses under the 
assumption of dominant and recessive models. 
Under the dominant assumption, the disease 
allele frequencies were estimated to be 0*00025 
and 0-00088 for the US and the Dutch data 
respectively, and 0-022 and 0-042 for the US 
and the Dutch respectively under the recessive 
model. The affecteds only method was used in 
the linkage analysis by making the phenotype 
of unaffected family members unknown.
In order to assess the possible linkage of 
N T D  to the PAX3 gene, the marker PAX3  was 
selected for genotyping. Allele frequencies for 
this marker used in the US data set were as 
published25 (using control US population). For 
the Dutch data set, allele frequencies were 
calculated from 37 unrelated people (Dutch) 
selected from the same geographical areas as 
Dutch N T D  families. The allele frequencies 
from the two populations were not significantly 
different.
Results
Two point lod scores were calculated for vari­
ous recombination fractions assuming 0 m = 0 f, 
penetrance of 0-45 and autosomal dominant 
(table 1 ) or autosomal recessive models (table 
2 ). Results for affecteds only analysis showed 
exclusion of linkage between familial N T D  and 
the PAX3 gene to 9 • 9 cM on either side of the 
gene for the dominant model and to 3-63 cM 
on either side of the gene for the recessive 
model in the present families. Two point lod 
scores were also calculated assuming pene­
trance of 0-27 (tables 3 and 4). The two point 
lod score assuming the phenocopy rate of zero 
showed similar results (data not shown).
Table 4 Lod scores under recessive model, penetrance = 0'27
Neural tube defects and P A X 3 gene
0
0-0 0-01 0'05 0-1 0-2 0-3 0-4
US — 3*15 -2 -49 —1*16 -0*47 0-00 0-07 0*03
Dutch —1-11 -0 -8 4 — 0-22 011 0-27 0’20 0-08
Sum — 4*26 — 3*33 —1-38 — 0-36 0-27 0’27 0*11
No evidence for genetic heterogeneity was 
detected using the H O M O G  program 29 (data 
not shown).
Discussion
The application of linkage analysis to disease 
which display complex traits carries several 
difficulties because of: ( 1 ) the uncertainty of 
mode of inheritance and penetrance, (2 ) the 
small family sizes, (3) the unclear phenotypes, 
and (4) genetic heterogeneity . 30" 32 However, the 
complex traits are among the most common 
human disorders and efforts should be made 
to unravel such problems. Linkage analysis has 
been used successfully to locate predisposing 
genes for complex traits such as familial Alz­
heimer’s disease. 33
Although N TD s have been considered to 
have multifactorial threshold inheritance with 
the phenotype depending upon an interaction 
between genetic and environmental factors, 
monogenic inheritance with a major con­
tribution of environmental factors has been 
suggested . 34 Another study35 in which SBO was 
included with SB and sacral agenesis supported 
autosomal dominant inheritance with se­
gregation distortion similar in type to that seen 
with alleles at the T  locus in the m ouse . 36 
However, it is possible that a gene for N T D  
segregates in an autosomal recessive m anner . 37 
In addition, autosomal recessive inheritance 
has been suggested for some families with 
anencephaly . 3839 If there is a major gene se­
gregating in N T D  families either in an auto­
somal dominant or autosomal recessive m an­
ner, linkage analysis is likely to be able to locate 
such a gene.
Because the mode of inheritance and pene­
trance are uncertain, we analysed the data u n ­
der the assumption of both autosomal 
dominant and autosomal recessive models. 
One of the worst potential model mis- 
specifications is the misspecification of dom­
inance40 and therefore the recessive model was 
also applied in our data. Assumption of a high 
penetrance may falsely generate exclusion of 
the linkage whereas a low penetrance approach 
may reduce the power to detect linkage. We 
carried out the analysis using a variety of para­
meters with different levels of penetrance: 0*45 
and 0’27. Our result did not show evidence of 
linkage between familial N T D  and this marker 
which is located within the PAX3 region itself.
SBO has been considered a variable ex­
pression of the SB gene .41"44 Radiography of 
the spine was not performed in the unaffected 
subjects in our series apart from two subjects 
from the US families and two from the Dutch 
family who had SBO detected on radiography 
of the spine performed for other medical
reasons. Therefore the analysis was performed 
including SBO. However, because there were 
only four SBO in the data set, excluding them 
did not have significant influence on lod scores.
There has been concern regarding genetic 
heterogeneity based on the level of the defects 
(high level SB above T i l  v low level SB) 
perhaps representing defects in neurulation ver­
sus canalisation45 However, this question re­
mains controversial . 46 It was also suggested that 
AC may be distinct from SB45 although both 
may occur in the same family and the oc­
currence rate of each type is increased in sibs 
of children affected by the other .47 In this re­
spect, the same m ajor gene is likely to contribute 
to  different phenotypes. Nevertheless, if in fact 
different phenotypes such as SB and A C are 
caused by different loci, combining data may 
result in a false negative lod score. This is not 
the  case in our series. All affected subjects in 
the US families had SB and SBO whereas the 
affected subjects in the D u tch  data had  varieties 
of N T D , SB, AC, and EC . However, only the 
patients with SB, SBO, and EC from the D utch 
families were genotyped. Linkage was not de- 
tected in the US families with only SB, a result 
similar to that from the D utch  subset.
Such “exclusion” results must be interpreted 
cautiously, especially since the phenocopy rate 
is only approximate. However, our data exclude 
PAX3 as a major gene in the present families 
with familial N T D  and familial SB under the 
assumption of the above parameters.
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